Kuwait Life Sciences Company
Asia, Al Kuwayt, Kuwait, Safat
Description
KLSC aims to be the Middle East’s premiere Life Sciences and Healthcare technology transfer and investment company
Investor Profile
Kuwait Life Sciences Company has made 4 investments, with 0 in the past 12 months and 25% as lead.
Stage Focus
- Series B (50%)
- Series C (25%)
- Private Equity (25%)
Country Focus
- United Arab Emirates (50%)
- France (25%)
- United Kingdom (25%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Medical Device
- Biotechnology
- Oncology
- Pharmaceutical
- Health Care
- Manufacturing
- Clinical Trials
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
